Back to the main directory
Press Release
- Glacier Bancorp, Inc. Announces Acquisition of Bank of Idaho Holding Co. by GlobeNewsWire
- Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference by GlobeNewsWire
- Spartan Delta Corp. Announces Preliminary 2025 Guidance, Acceleration of Duvernay Development Program, and $50 Million Equity Offering by GlobeNewsWire
- RPM Announces Appointment of Three New Board Members by BusinessWire
- Atkore Inc. Announces First Quarter Fiscal Year 2025 Earnings Release Date and Conference Call by BusinessWire
- Centerra Gold Provides Notice of Fourth Quarter 2024 Results Release and Conference Call by GlobeNewsWire
- B2Gold Announces Total Consolidated Gold Production for 2024 of 804,778 oz, Within the Revised 2024 Guidance Range; Total Gold Production for 2025 Anticipated to be Between 970,000 and 1,075,000 oz; Goose Project Remains On Track for First Gold in Q2 2025 by GlobeNewsWire
- UPDATE - Spartan Delta Corp. Announces Preliminary 2025 Guidance, Acceleration of Duvernay Development Program, and $50 Million Equity Offering by GlobeNewsWire
- Talen Energy Supply Announces Successful Completion of Consent Solicitation for Amendments to 8.625% Senior Secured Notes Due 2030 by GlobeNewsWire
- Bimini Capital Management to Announce Fourth Quarter 2024 Results by GlobeNewsWire
- Interfor to Announce Fourth Quarter and Fiscal 2024 Results on February 13, 2025 by GlobeNewsWire
- B2Gold Announces Amended Shareholder Return Strategy, including New Dividend Framework and Intention to Implement a Normal Course Issuer Bid by GlobeNewsWire
- Nxera Pharma Provides Update on Neurocrine’s Progress with its Partnered Muscarinic Agonist Portfolio by GlobeNewsWire
- Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on February 25, 2025 by GlobeNewsWire
- Teva gibt Zusammenarbeit zur Vermarktung des Formycon Biosimilar-Kandidaten für Eylea® (Aflibercept) in großen Teilen Europas und in Israel bekannt by GlobeNewsWire
- HUTCHMED Announces NMPA Full Approval for ORPATHYS® (savolitinib) in China for Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC by GlobeNewsWire
- CoinShares Reduces Management Fees on Europe's Largest Bitcoin Physical ETP, Aligning Global Product Offering by GlobeNewsWire
- Šnipiškiu Urban korteriarendusprojekti ehitusega alustamine (Vilnius, Leedu) by GlobeNewsWire
- Aktsiaseltsi Silvano Fashion Group auditeerimiskohustuse täitmisest by GlobeNewsWire
- Results of the Reopened Offer in connection with Doodle's public tender offer (the "Tender Offer") for shares by GlobeNewsWire
- Santhera erhält positive Empfehlung vom Scottish Medicines Consortium für den Einsatz von AGAMREE® (Vamorolon) bei Patienten mit Duchenne-Muskeldystrophie in Schottland by GlobeNewsWire
- Sandoz to confirm strategic roadmap and highlight pipeline catalysts at 43rd Annual J.P. Morgan Healthcare Conference by GlobeNewsWire
- TextMagic grupi müügitulemused 2024. aasta IV kvartalis by GlobeNewsWire
- Nouvelle composition du Conseil d’administration d’Implenia by EQS Group AG
- EQS-News: Branicks has won another tenant for “Neustadt Centrum” in Halle with Smyths Toys by EQS Group AG